Mesa Laboratories, Inc.
MLAB
$105.48
-$1.87-1.74%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.38% | 4.12% | 7.39% | 8.33% | 11.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.38% | 4.12% | 7.39% | 8.33% | 11.47% |
| Cost of Revenue | 2.23% | 7.87% | 11.48% | 10.86% | 8.77% |
| Gross Profit | 4.06% | 1.98% | 5.04% | 6.86% | 13.10% |
| SG&A Expenses | 3.86% | 5.22% | 5.10% | 5.01% | 3.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.23% | 6.05% | 7.76% | 7.08% | 5.13% |
| Operating Income | 5.37% | -16.26% | 2.07% | 33.29% | 376.48% |
| Income Before Tax | 101.54% | 105.21% | 102.73% | 103.35% | 102.16% |
| Income Tax Expenses | -33.18% | 150.68% | 144.10% | 147.27% | 137.08% |
| Earnings from Continuing Operations | 440.02% | 101.50% | 99.36% | 99.75% | 99.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 440.02% | 101.50% | 99.36% | 99.75% | 99.22% |
| EBIT | 5.37% | -16.26% | 2.07% | 33.29% | 376.48% |
| EBITDA | -0.74% | -3.76% | -4.26% | -0.81% | 19.38% |
| EPS Basic | 445.08% | 101.44% | 99.34% | 99.75% | 99.25% |
| Normalized Basic EPS | 174.54% | 223.28% | -15.32% | 231.40% | 3,855.56% |
| EPS Diluted | 426.96% | 101.39% | 99.30% | 99.70% | 99.22% |
| Normalized Diluted EPS | 174.64% | 224.01% | -16.17% | 227.03% | 3,836.80% |
| Average Basic Shares Outstanding | 1.73% | 1.46% | 1.15% | 0.81% | 0.61% |
| Average Diluted Shares Outstanding | 1.99% | 1.72% | 1.25% | 1.35% | 0.99% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 1.30% | 68.71% | -157.03% | -405.88% | -128.58% |